Analysis VENUS MEDTECH HANGZHOU INC. (VMTHF)
5/25/2024
Analysis of VENUS MEDTECH HANGZHOU INC. (VMTHF)
Venus MedTech Hangzhou Inc. (VMTHF) has been trading at a consistent price of 0.01080 over the past several days. The Relative Strength Index (RSI) indicator is at 0.00000, indicating a neutral stance. The Moving Average Convergence Divergence (MACD) indicator shows a negative value of -0.04094, with the MACD line below the signal line, suggesting a bearish trend.The Simple Moving Average (SMA) and Exponential Moving Average (EMA) are both at 0.01080, indicating stability in the price trend. However, the Weighted Moving Average (WMA) is slightly lower at 0.01080.
Overall, based on the current indicators, Venus MedTech Hangzhou Inc. is showing a neutral to slightly bearish trend in the short term. Traders and investors may want to closely monitor the price movements and key indicators for potential changes in the trend.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago. The range of estimates is between $1.27 and $1.36, with 26 analysts providing forecasts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, lower than the $1.46 reported a year ago. The EPS estimates range from $1.44 to $1.63, with 25 analysts contributing to the estimates.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, up from $6.13 in the previous year. The EPS estimates for the full year range from $6.43 to $6.92, with 39 analysts providing forecasts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 in the previous year. The EPS estimates for the upcoming year range from $6.40 to $7.90, with 39 analysts contributing to the estimates.
Overall, the analysts are generally forecasting an increase in earnings per share for both the current and next fiscal years compared to the previous periods, indicating positive growth expectations for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, the following conclusions can be drawn:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
Overall, the analysts are generally optimistic about the company's future sales performance, with expected growth in both quarterly and annual sales over the coming quarters and years.
Growth estimates
Based on the consensus estimates provided:- The company is expected to have a growth rate of 7.5% in the current year.
- For the next quarter, the growth rate is estimated to be 4.8%.
- In the current quarter, the growth rate is projected to be 5.6%.
- Over the next year, the growth rate is forecasted to be 9.7%.
- Looking ahead over the next 5 years, the company is expected to have a compound annual growth rate (CAGR) of 11%.
- However, when comparing to the past 5 years, the company had a higher CAGR of 20.15%.
These estimates suggest that the company is expected to experience steady growth in the near future, with a slightly higher growth rate projected for the next 5 years compared to the past 5 years.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57. It appears that the analysts are generally optimistic about the future price of the security, with the average and median estimates both higher than the current price.Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company. Here is a summary of the key information:1. Financials:
- Cash Flow: Operating cash flow (TTM) is $110,563,000,320 and levered free cash flow (TTM) is $84,726,874,112.
- Balance Sheet: Total cash (MRQ) is $67,150,000,128, total debt (MRQ) is $104,590,000,128, current ratio (MRQ) is 1.037, book value per share (MRQ) is $4.837, total cash per share (MRQ) is $4.379, and total debt to equity ratio (MRQ) is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue (TTM) is $381,623,009,280, diluted EPS (TTM) is $6.44, gross profit (TTM) is $169,148,000,000, revenue per share (TTM) is $24.537, net income to common (TTM) is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets (TTM): 22.073999%
- Return on Equity (TTM): 147.25%
2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Average 10-Day Volume: 52,903,608
- Average 90-Day Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%
3. Valuation Metrics:
- PEG Ratio: 26.213001
- Forward P/E: 26.213001
- Trailing P/E: 29.428572
- Enterprise Value: $2,948,462,018,560
- Price to Book (MRQ): 39.181313
- Price to Sales (TTM): 7.6151557
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672
4. Stock Price Summary:
- Beta: 1.264
- 50-Day Moving Average: $173.6936
- 200-Day Moving Average: $180.7906
- 52-Week Low: $164.08
- 52-Week High: $199.62
- 52-Week Change: 8.253%
5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5266761603816345%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5108758755701854%
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management strategies.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. The operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. The net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023.
6. The company has been able to maintain a healthy EBITDA margin, which suggests strong operational performance.
7. The basic and diluted earnings per share have shown an upward trend, indicating growth in profitability on a per-share basis.
8. The company's effective tax rate has remained relatively stable over the years, indicating consistent tax planning strategies.
9. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There has been a consistent increase in shareholders' equity, indicating a positive trend in the company's financial health.
MACD of VMTHF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
